Feature Channels:

Cell Biology

Add to Favorites Subscribe Share
fbshare-Cell Biology

Showing results

110 of 6949
Newswise: Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin’s Lymphoma
  • Embargo expired:
    17-Sep-2019 3:45 PM EDT

Article ID: 718718

Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin’s Lymphoma

Perelman School of Medicine at the University of Pennsylvania

Treating non-Hodgkin’s lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered.

Released:
10-Sep-2019 9:00 AM EDT

Research Results

Channels:

Cancer, Cell Biology, Immunology, Medical Meetings

Languages:

English

Embargo will expire:
19-Sep-2019 11:00 AM EDT
Released to reporters:
17-Sep-2019 2:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Sep-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: 211171_web.jpg

Article ID: 719109

'Death Star' bacterial structures that inject proteins can be tapped to deliver drugs

San Diego State University

By scraping tubeworms off the bottom of boats in the San Diego harbor to study them, San Diego State University

Released:
17-Sep-2019 1:05 PM EDT

Research Results

Channels:

All Journal News, Biotech, Cancer, Cell Biology, Vaccines

Languages:

English

Newswise: Every Step a Cell Takes, Every Move They Make -- Scientists will be Watching
  • Embargo expired:
    17-Sep-2019 11:00 AM EDT

Article ID: 718943

Every Step a Cell Takes, Every Move They Make -- Scientists will be Watching

American Institute of Physics (AIP)

An interdisciplinary team has found a solution to a problem plaguing developmental biology -- long-term cell tracking and manipulation. Researchers painstakingly developed an automated microfluidic device for the stable imaging of mice embryonic stem cells over a three-day period.

Released:
13-Sep-2019 9:35 AM EDT
  • Embargo expired:
    17-Sep-2019 9:00 AM EDT

Article ID: 718722

Cancer cells turn to cannibalism to survive chemotherapy, study suggests

The Rockefeller University Press

Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells. The study, which will be published September 17 in the Journal of Cell Biology, suggests that this act of cannibalism provides these cancer cells with the energy they need to stay alive and initiate tumor relapse after the course of treatment is completed.

Released:
10-Sep-2019 10:00 AM EDT

Article ID: 719067

FDA Awards AnaBios Grant to Further Develop Preclinical Assay Using Human Primary Cardiomyocytes

AnaBios

The U.S. Food and Drug Administration (FDA) has named AnaBios the recipient of a grant to further develop its unique drug discovery platform utilizing muscle cells from the human heart (cardiomyocytes).

Released:
17-Sep-2019 8:20 AM EDT
Newswise: Dana-Farber Cancer Institute receives $5 million gift to create the Edward P. Evans Center for Myelodysplastic Syndromes
  • Embargo expired:
    17-Sep-2019 8:00 AM EDT

Article ID: 719007

Dana-Farber Cancer Institute receives $5 million gift to create the Edward P. Evans Center for Myelodysplastic Syndromes

Dana-Farber Cancer Institute

A $5 million gift from the Edward P. Evans Foundation will create the Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Dana-Farber Cancer Institute.

Released:
16-Sep-2019 11:05 AM EDT
Embargo will expire:
19-Sep-2019 11:00 AM EDT
Released to reporters:
17-Sep-2019 3:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Sep-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New Method Reveals How Damage Occurs in Human Biological Cells Due to Mechanical Fatigue

Article ID: 719057

New Method Reveals How Damage Occurs in Human Biological Cells Due to Mechanical Fatigue

Florida Atlantic University

Researchers have developed a novel way to measure how mechanical fatigue affects biological cells. They also have established the important role of this effect in influencing physical properties of biological cells such as red blood cells (RBCs). This new technique assesses the mechanical integrity and fatigue behavior of RBCs using a general microfluidics method that incorporates amplitude-modulated electro-deformation. This method has important applications for mechanical fatigue studies in conjunction with other microenvironments related to health and materials engineering.

Released:
16-Sep-2019 4:30 PM EDT
Embargo will expire:
18-Sep-2019 7:00 AM EDT
Released to reporters:
16-Sep-2019 10:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2019 7:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 6949

Chat now!